183 related articles for article (PubMed ID: 33407243)
21. Multiple sclerosis incidence rate in southern Iran: a Bayesian epidemiological study.
Asmarian N; Sharafi Z; Mousavi A; Jacques R; Tamayo I; Bind MA; Abutorabi-Zarchi M; Moradian MJ; Izadi S
BMC Neurol; 2021 Aug; 21(1):309. PubMed ID: 34376167
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of multiple sclerosis in Iran: a systematic review.
Etemadifar M; Sajjadi S; Nasr Z; Firoozeei TS; Abtahi SH; Akbari M; Fereidan-Esfahani M
Eur Neurol; 2013; 70(5-6):356-63. PubMed ID: 24192707
[TBL] [Abstract][Full Text] [Related]
23. Does the multiple sclerosis (MS) map need to change again? An update of MS prevalence in Mazandaran province of Iran in 2018.
Baghbanian SM; Cheraghmakani H; HabibiSaravi R; Azar A; Ghasemihamedani F
BMC Neurol; 2020 Feb; 20(1):52. PubMed ID: 32050931
[TBL] [Abstract][Full Text] [Related]
24. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
25. The trend of incidence, prevalence, and DALY of multiple sclerosis in the Middle East and Northern Africa region compared to global, West Europe and, Iran's corresponding values during 1990-2017: Retrieved from global burden of diseases data.
Abbastabar H; Bitarafan S; Mohammadpour Z; Mohammadianinejad SE; Harirchian MH
Mult Scler Relat Disord; 2021 Jul; 52():102949. PubMed ID: 33894481
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of Multiple Sclerosis in Torbat-e Heydarieh (Northeast of Iran) during 1982-2016.
Moghaddam VK; Sarmadi M; Tatari M; Najafi F; Esmaeili A; Hadei M
Mult Scler Relat Disord; 2018 Aug; 24():184-189. PubMed ID: 30077941
[TBL] [Abstract][Full Text] [Related]
27. Time-trend analysis and developing a forecasting model for the prevalence of multiple sclerosis in Kohgiluyeh and Boyer-Ahmad Province, southwest of Iran.
Mousavizadeh A; Dastoorpoor M; Naimi E; Dohrabpour K
Public Health; 2018 Jan; 154():14-23. PubMed ID: 29128732
[TBL] [Abstract][Full Text] [Related]
28. Breast Cancer Trend in Iran from 2000 to 2009 and Prediction till 2020 using a Trend Analysis Method.
Zahmatkesh B; Keramat A; Alavi N; Khosravi A; Kousha A; Motlagh AG; Darman M; Partovipour E; Chaman R
Asian Pac J Cancer Prev; 2016; 17(3):1493-8. PubMed ID: 27039796
[TBL] [Abstract][Full Text] [Related]
29. Evidence of an increased prevalence of multiple sclerosis: a population-based study of Tehran registry during 1999-2018.
Almasi-Hashiani A; Sahraian MA; Eskandarieh S
BMC Neurol; 2020 May; 20(1):169. PubMed ID: 32359352
[TBL] [Abstract][Full Text] [Related]
30. Investigating the trends of incidence rates of breast cancer in Southern Iran: a population based survey.
Haghpanah S; Hosseini-Bensenjan M; Ramzi M; Khosravizadegan Z; Rezaianzadeh A
BMC Womens Health; 2023 Nov; 23(1):589. PubMed ID: 37950182
[TBL] [Abstract][Full Text] [Related]
31. Prostate Cancer in Iran: Trends in Incidence and Morphological and Epidemiological Characteristics.
Pakzad R; Rafiemanesh H; Ghoncheh M; Sarmad A; Salehiniya H; Hosseini S; Sepehri Z; Afshari-Moghadam A
Asian Pac J Cancer Prev; 2016; 17(2):839-43. PubMed ID: 26925689
[TBL] [Abstract][Full Text] [Related]
32. The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.
Sharafaddinzadeh N; Moghtaderi A; Majdinasab N; Dahmardeh M; Kashipazha D; Shalbafan B
Clin Neurol Neurosurg; 2013 Aug; 115(8):1271-5. PubMed ID: 23273383
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and incidence of multiple sclerosis in Isfahan, Iran between 1996 and 2021: A population-based study.
Barzegar M; Vaheb S; Mirmosayyeb O; Ashtari F; Afshari-Safavi A; Adibi I; Shaygannejad A; Mazaheri S; Rahimi M; Shaygannejad V
Mult Scler Relat Disord; 2024 Apr; 84():105479. PubMed ID: 38359695
[TBL] [Abstract][Full Text] [Related]
34. Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends.
Rafiemanesh H; Salehiniya H; Lotfi Z
Asian Pac J Cancer Prev; 2016; 17(3):1393-7. PubMed ID: 27039778
[TBL] [Abstract][Full Text] [Related]
35. Increasing Incidence and Prevalence of Multiple Sclerosis in Puerto Rico (2013-2016).
Chinea A; Ríos-Bedoya CF; Vicente I; Rubí C; García G; Rivera A; Díaz A; Romero EE; Hernández Silvestrini Y; Díaz Y;
Neuroepidemiology; 2017; 49(3-4):106-112. PubMed ID: 29136613
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and Incidence of Multiple Sclerosis in Tehran, Iran.
Eskandarieh S; Heydarpour P; Elhami SR; Sahraian MA
Iran J Public Health; 2017 May; 46(5):699-704. PubMed ID: 28560202
[TBL] [Abstract][Full Text] [Related]
37. The Trend in Histological Changes and the Incidence of Esophagus Cancer in Iran (2003-2008).
Rafiemanesh H; Maleki F; Mohammadian-Hafshejani A; Salemi M; Salehiniya H
Int J Prev Med; 2016; 7():31. PubMed ID: 26955461
[TBL] [Abstract][Full Text] [Related]
38. Gender and social disparities in esophagus cancer incidence in Iran, 2003-2009: a time trend province-level study.
Kiadaliri AA
Asian Pac J Cancer Prev; 2014; 15(2):623-7. PubMed ID: 24568468
[TBL] [Abstract][Full Text] [Related]
39. Impact of the first Gulf war on multiple sclerosis risk in Kuwait: a quasi-experimental study.
Akhtar S; Al-Hashel JY; Alroughani R
BMC Neurol; 2023 Jul; 23(1):259. PubMed ID: 37407920
[TBL] [Abstract][Full Text] [Related]
40. Trends in gastrointestinal cancer incidence in Iran, 2001-2010: a joinpoint analysis.
Darabi M; Asadi Lari M; Motevalian SA; Motlagh A; Arsang-Jang S; Karimi Jaberi M
Epidemiol Health; 2016; 38():e2016056. PubMed ID: 27923268
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
